ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

ILMN Illumina Inc

121.00
-3.68 (-2.95%)
After Hours
Last Updated: 00:12:08
Delayed by 15 minutes
Share Name Share Symbol Market Type
Illumina Inc NASDAQ:ILMN NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -3.68 -2.95% 121.00 120.00 122.00 126.30 122.19 125.87 1,630,426 00:12:08

ILMN LOSS NOTICE: Rosen Law Firm Reminds Illumina, Inc. Investors of Important Deadline in Class Action – ILMN

27/12/2016 8:03pm

Business Wire


Illumina (NASDAQ:ILMN)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Illumina Charts.

Rosen Law Firm, a global investor rights law firm, reminds purchasers of Illumina, Inc. securities (NASDAQ:ILMN) from July 26, 2016 through October 10, 2016, inclusive (the “Class Period”) of the important February 14, 2017 lead plaintiff deadline in the class action. The lawsuit seeks to recover damages for Illumina investors under the federal securities laws.

To join the Illumina class action, go to http://rosenlegal.com/cases-1014.html or call Phillip Kim, Esq. or Kevin Chan, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or kchan@rosenlegal.com for information on the class action.

NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. YOU MAY RETAIN COUNSEL OF YOUR CHOICE.

According to the lawsuit, throughout the Class Period defendants issued materially false and misleading statements to investors and/or failed to disclose that: (1) Illumina was experiencing a large decline in high throughput sequencing instrument sales; (2) the decline was negatively impacting Illumina’s revenue; (3) Illumina lacked visibility into trends that could have a substantial impact on Illumina’s financial results; (4) as such, Illumina’s revenue guidance was unreliable and overstated; and (5) as a result, Defendants’ positive statements about Illumina’s business, operations, and prospects, were false and misleading and/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.

A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than February 14, 2017. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, go to http://rosenlegal.com/cases-1014.html or to discuss your rights or interests regarding this class action, please contact Phillip Kim, Esq. or Kevin Chan, Esq. of Rosen Law Firm toll free at 866-767-3653 or via e-mail at pkim@rosenlegal.com or kchan@rosenlegal.com. Attorney Advertising. Prior results do not guarantee a similar outcome.

Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.

The Rosen Law Firm, P.A.Laurence Rosen, Esq.Phillip Kim, Esq.Kevin Chan, Esq.275 Madison Avenue, 34th FloorNew York, NY 10016Tel: (212) 686-1060Toll Free: (866) 767-3653Fax: (212) 202-3827lrosen@rosenlegal.compkim@rosenlegal.comkchan@rosenlegal.comwww.rosenlegal.com

1 Year Illumina Chart

1 Year Illumina Chart

1 Month Illumina Chart

1 Month Illumina Chart

Your Recent History

Delayed Upgrade Clock